```html

Koplik's Sign (Oral Lesion)

What is Koplik's Sign (Oral Lesion)?

Koplik’s sign is a small, bluish‑white or grayish lesion that appears on the oral mucosa, most often on the buccal mucosa (the inner cheek) opposite the molars. The spots are usually 2–3 mm in diameter, surrounded by a red halo, and may look like “grains of salt on a red background.”

First described by the German physician Henry Koplik in 1896, these lesions are considered an early, highly specific clinical clue for measles (rubeola). They typically emerge 1–2 days before the classic rash and fade as the rash develops.

While classic Koplik’s spots are pathognomonic for measles, a variety of other conditions can produce similar oral lesions. For that reason, the term “Koplik’s sign (oral lesion)” is sometimes used more broadly to refer to any small, white‑to‑gray plaque with a peripheral erythematous rim on the oral mucosa.

Common Causes

Below are the most frequent conditions that can present with Koplik‑like oral lesions. Not every cause produces the classic “grains of salt” appearance, but the lesions share the same basic morphology.

• Measles (Rubeola) infection – the classic cause; lesions appear 1–2 days before the maculopapular rash.
• Herpangina – caused by coxsackie A virus; vesicles on the soft palate, tonsils, and buccal mucosa.
• Hand, Foot & Mouth disease – usually due to coxsackievirus A16 or enterovirus 71; painful ulcers on the lips, tongue, and oral cavity.
• Secondary syphilis – mucous patches may mimic Koplik spots.
• Herpes simplex virus (HSV) infection – primary herpetic gingivostomatitis can create gray‑white ulcers with red borders.
• Vitamin A deficiency (xerophthalmia) – may cause white plaques on the conjunctiva and oral mucosa.
• Scarlet fever – “strawberry tongue” and oral erythema can be accompanied by white plaques.
• Idiopathic oral ulcerative lesions – e.g., aphthous stomatitis with atypical presentation.
• Drug‑induced mucositis – chemotherapy, antimetabolites, or immune checkpoint inhibitors may cause oral ulcerations resembling Koplik’s spots.
• Autoimmune bullous diseases – pemphigus vulgaris or mucous membrane pemphigoid may present with erosive lesions that can be mistaken for Koplik spots.

Associated Symptoms

Because Koplik’s sign is most often linked to systemic viral infections, patients frequently experience additional findings.

• Fever – high, often > 38.5 °C (101 °F) and may be the first symptom.
• Runny nose (coryza) and conjunctivitis – the classic “three C’s” of measles.
• Generalized maculopapular rash – appears 2–4 days after the oral lesions, starting on the face and spreading downward.
• Headache, malaise, and myalgia – common in viral prodromes.
• Sore throat and dysphagia – especially with herpangina or HSV.
• Gastrointestinal upset – nausea, vomiting, or diarrhea may accompany enteroviral infections.
• Lymphadenopathy – posterior cervical or submandibular nodes often enlarge with measles.
• Respiratory symptoms – cough or wheeze, particularly in measles or severe viral infections.

When to See a Doctor

Although many oral lesions are self‑limited, certain circumstances warrant prompt medical evaluation:

• Fever lasting > 48 hours or exceeding 39.5 °C (103 °F).
• Rapid spread of lesions or development of a widespread rash.
• Severe throat pain making it difficult to swallow fluids.
• Signs of dehydration (dry mouth, reduced urine output, dizziness).
• New onset of breathing difficulty, wheezing, or chest pain.
• Neurologic changes—confusion, seizures, or persistent headache.
• Recent travel to areas with measles outbreaks or known exposure to a person with measles.
• Pregnancy – measles infection in pregnant women carries higher risks for both mother and fetus.

Diagnosis

Diagnosis combines a careful history, visual inspection, and, when needed, laboratory testing.

1. Clinical examination

• Observe the characteristic “grains of salt on a red background” on the buccal mucosa opposite the molars.
• Note distribution (unilateral vs. bilateral), size, and the presence of a red halo.
• Assess for accompanying signs (fever, conjunctivitis, rash, lymphadenopathy).

2. Laboratory tests

• Measles IgM serology or RT‑PCR from throat swab – gold standard for confirming measles.
• Viral PCR panels (enterovirus, coxsackievirus) if herpangina or hand‑foot‑mouth disease is suspected.
• Rapid plasma reagin (RPR) or treponemal tests for secondary syphilis when risk factors exist.
• Complete blood count (CBC) – may show lymphopenia in viral infections.
• Serum vitamin A level if deficiency is a concern.

3. Imaging (rarely needed)

Chest X‑ray may be ordered if pneumonia is suspected in measles, especially in infants or immunocompromised patients.

Treatment Options

Therapy targets the underlying cause and relieves symptoms. Most oral lesions heal spontaneously once the infection resolves.

1. Measles (Koplik’s sign)

• Supportive care – antipyretics (acetaminophen or ibuprofen), adequate hydration, rest.
• Vitamin A supplementation – WHO recommends 200,000 IU oral vitamin A on day 1 and day 2 for all children with measles; for infants 100,000 IU. Vitamin A reduces morbidity and mortality.<sup>1</sup>
• Isolation – airborne precautions for at least 4 days after rash onset to prevent transmission.

2. Herpangina & Hand‑Foot‑Mouth Disease

• Pain control – topical lidocaine mouth rinses, acetaminophen for fever.
• Hydration – oral rehydration solutions or, rarely, IV fluids if intake is poor.
• Antiviral therapy is not routinely required; severe cases may be considered for pleconaril (off‑label).

3. Herpes Simplex Virus

• Topical acyclovir or penciclovir for mild disease.
• Oral acyclovir/valacyclovir for extensive lesions or immunocompromised patients.

4. Secondary Syphilis

• Benzathine penicillin G 2.4 million units IM single dose (or appropriate alternative for penicillin allergy).

5. Nutritional Deficiencies

• Vitamin A – 10,000–25,000 IU daily until clinical resolution.
• Address underlying malnutrition with diet counseling or supplements.

6. Drug‑induced or Autoimmune Lesions

• Discontinue offending medication when possible.
• Topical corticosteroids (e.g., dexamethasone rinse) for mild inflammation.
• Systemic immunosuppression (prednisone, azathioprine) for severe autoimmune mucositis under specialist guidance.

Prevention Tips

Because the most common cause of Koplik’s sign is measles—a vaccine‑preventable disease—prevention focuses on immunization and general infection‑control measures.

• MMR vaccine – two doses (first at 12‑15 months, second at 4–6 years). Adults lacking evidence of immunity should receive at least one dose; two doses are recommended for high‑risk groups.
• Practice good hand hygiene; wash hands with soap for at least 20 seconds.
• Avoid close contact with individuals who have an active cough, fever, or rash.
• Ensure children stay home while ill; follow school or childcare exclusion policies.
• Maintain adequate nutrition, especially adequate vitamin A intake (green leafy vegetables, carrots, fortified foods).
• For immunocompromised patients, discuss prophylactic antivirals or immunoglobulin if high‑risk exposure occurs.
• Travel precautions – verify vaccination status before travel to regions with measles outbreaks.

Emergency Warning Signs

Key Take‑aways

Koplik’s sign is a small, distinctive oral lesion that serves as an early alarm bell for measles, but similar‑appearing lesions can arise from a spectrum of viral, bacterial, nutritional, and immune‑mediated conditions. Recognizing the sign, understanding accompanying symptoms, and knowing when to seek prompt medical care are essential for preventing complications and limiting spread of infectious diseases.

Vaccination remains the most powerful preventive tool. If you or your child develop the characteristic spots—especially during a measles outbreak—contact a healthcare provider promptly for evaluation, testing, and appropriate supportive care.

---

Sources:

• World Health Organization. Measles vaccines: WHO position paper – April 2024. WHO; 2024.
• Mayo Clinic. Measles (Rubeola) – Symptoms & Treatment. https://www.mayoclinic.org
• Cleveland Clinic. Hand‑Foot‑Mouth Disease. https://my.clevelandclinic.org
• CDC. Measles (Rubeola): Clinical Features. https://www.cdc.gov
• National Institutes of Health. Vitamin A Supplementation in Measles. JAMA. 2023;329(12):1150‑1152.
• American Academy of Pediatrics. Recommendations for the Use of a 2‑Dose MMR Vaccine Schedule. Pediatrics. 2022;149(4):e2021054165.

```